Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Jon C. Ogg | Aug 20, 2013 at 2:57 PM EDT

Medical Marijuana Stock Scam Warning — for Real

ThinkstockIt appears that scam artists are now targeting medical marijuana and legalized marijuana schemes to part you from your money.…

Jon C. Ogg | Aug 12, 2013 at 9:20 AM EDT

Merck Temodar Gets Generic Competition in Brain Cancer

ThinkstockMerck & Co. Inc. (NYSE: MRK) is seeing one more drug drive off the patent cliff. News was released on…

Jon C. Ogg | Aug 12, 2013 at 8:55 AM EDT

Short Interest Declines on Top Health Care Distribution and Technology Stocks to Buy

ThinkstockWhen short interest, or the amount of any specific stock sold short, starts to decline, that is usually a flashing…

Jon C. Ogg | Aug 8, 2013 at 10:50 AM EDT

Opexa Morphs from Mystery Mega-Rally to Money Killer

Jon OggOpexa Therapeutics Inc. (NASDAQ: OPXA) may have just become the villain of Wall Street in emerging pharma and biotech.…

Jon C. Ogg | Jul 30, 2013 at 9:45 AM EDT

New State-Sponsored Stem Cell Study Launches for Alzheimer’s Disease

ThinkstockThe war against Alzheimer’s disease is getting another round of stem cell research thrown at it. While this involves a…

Jon C. Ogg | Jul 25, 2013 at 11:30 AM EDT

Sequenom: The Train Wreck Returns

ThinkstockSequenom Inc. (NASDAQ: SQNM) is back in the news, but not in a good way. The company that saw its…

247sam | Jul 24, 2013 at 9:45 AM EDT

Cities Where the Most People Have Heart Attacks

ThinkstockHeart disease, which causes heart attacks, is the leading cause of death in the United States. More than 700,000 Americans…

Jon C. Ogg | Jul 24, 2013 at 8:30 AM EDT

Specialty Pharmaceutical Stocks That May End Up as Takeover Candidates

ThinkstockTypically, specialty pharmaceutical companies either provide generic versions of former top-selling branded drugs or they may focus on drugs that…

Douglas A. McIntyre | Jul 22, 2013 at 10:20 AM EDT

Royal Birth: Likely Corporate Sponsors Look At 240 Million Pound Windfall

ThinkstockThe U.K.’s royal family is wealthy, but likely not wealthy enough to pass up sponsorships as the heir to the…

Paul Ausick | Jul 19, 2013 at 9:55 AM EDT

REIT IPO Prices at Low End of Range

ThinkstockPhysicians Realty Trust (NYSE: DOC) priced its initial public offering (IPO) at $11.50 a share, the low end of the…

Paul Ausick | Jul 17, 2013 at 8:20 AM EDT

Abbott Labs Company Earnings Light on Revenues

ThinkstockAbbott Laboratories (NYSE: ABT) reported second-quarter 2013 results before markets opened this morning. The drugmaker reported adjusted diluted earnings per…

Paul Ausick | Jul 16, 2013 at 9:00 AM EDT

Johnson & Johnson Company Earnings Send Shares to All-Time High

Wikimedia CommonsJohnson & Johnson (NYSE: JNJ) reported second-quarter 2013 results before markets opened this morning. The health care giant reported…

Jon C. Ogg | Jul 12, 2013 at 12:13 PM EDT

Will New Lung Cancer Drug FDA Approval Encourage More Smoking?

courtesy of NBN at German WikipediaThe news around tobacco and smoking cigarettes has been dominated by the trends around the…

Paul Ausick | Jul 12, 2013 at 8:30 AM EDT

WebMD Prescribes Higher Revenue and Profits

ThinkstockHealth information website WebMD Health Corp. (NASDAQ: WBMD) this morning raised its second-quarter estimates for revenues and profits, citing higher…

Jon C. Ogg | Jul 12, 2013 at 8:15 AM EDT

Cowen’s Eight Biotech Stocks to Buy That Could Beat Earnings: Alexion, Ariad and More

ThinkstockBiotechnology stocks have had an extremely solid first half of the year. The analysts at Cowen Group point out that…

1 … 300 301 302 303 304 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Medical Marijuana Stock Scam Warning — for Real

Merck Temodar Gets Generic Competition in Brain Cancer

Short Interest Declines on Top Health Care Distribution and Technology Stocks to Buy

Opexa Morphs from Mystery Mega-Rally to Money Killer

New State-Sponsored Stem Cell Study Launches for Alzheimer’s Disease

Sequenom: The Train Wreck Returns

Cities Where the Most People Have Heart Attacks

Specialty Pharmaceutical Stocks That May End Up as Takeover Candidates

Royal Birth: Likely Corporate Sponsors Look At 240 Million Pound Windfall

REIT IPO Prices at Low End of Range

Abbott Labs Company Earnings Light on Revenues

Johnson & Johnson Company Earnings Send Shares to All-Time High

Will New Lung Cancer Drug FDA Approval Encourage More Smoking?

WebMD Prescribes Higher Revenue and Profits

Cowen’s Eight Biotech Stocks to Buy That Could Beat Earnings: Alexion, Ariad and More

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

XRP vs Solana vs Ethereum: Which Altcoin is the Best Buy for Upside Right Now?

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

Health and Healthcare Articles

All Health and Healthcare Articles

Medical Marijuana Stock Scam Warning — for Real

Merck Temodar Gets Generic Competition in Brain Cancer

Short Interest Declines on Top Health Care Distribution and Technology Stocks to Buy

Opexa Morphs from Mystery Mega-Rally to Money Killer

New State-Sponsored Stem Cell Study Launches for Alzheimer’s Disease

Sequenom: The Train Wreck Returns

Cities Where the Most People Have Heart Attacks

Specialty Pharmaceutical Stocks That May End Up as Takeover Candidates

Royal Birth: Likely Corporate Sponsors Look At 240 Million Pound Windfall

REIT IPO Prices at Low End of Range

Abbott Labs Company Earnings Light on Revenues

Johnson & Johnson Company Earnings Send Shares to All-Time High

Will New Lung Cancer Drug FDA Approval Encourage More Smoking?

WebMD Prescribes Higher Revenue and Profits

Cowen’s Eight Biotech Stocks to Buy That Could Beat Earnings: Alexion, Ariad and More

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

XRP vs Solana vs Ethereum: Which Altcoin is the Best Buy for Upside Right Now?

Featured Reads

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up